LCM
ZURA icon

Lynx1 Capital Management’s Zura Bio ZURA Stock Holding History

Lynx1 Capital Management’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-9,917
Closed -$65.5K – 17
2023
Q3 		$65.5K Buy
+9,917
New +$66.3K 0.04% 17

Other funds holding ZURA

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lynx1 Capital Management's ZURA Position: Q4 2023 in Review

Lynx1 Capital Management sold out of Zura Bio (ZURA) in Q4 2023, closing a stake of 9,917 shares — an estimated $65.5K sold.

Lynx1 Capital Management first reported a position in ZURA in Q3 2023 and held it in 1 quarter. The position peaked at $65.5K in Q3 2023. 44 funds tracked by Wall St. Rank hold ZURA as of Q4 2023.

  • Lynx1 Capital Management reported no remaining Zura Bio position as of Q4 2023 after selling out during the quarter.
  • Lynx1 Capital Management sold 9,917 Zura Bio shares in Q4 2023, an estimated $65.5K.
  • Lynx1 Capital Management first reported a position in Zura Bio in Q3 2023 and held it in 1 quarter.
  • Lynx1 Capital Management's Zura Bio position peaked at $65.5K in Q3 2023.
  • 44 funds tracked by Wall St. Rank held Zura Bio as of Q4 2023.

Based on Lynx1 Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.